UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,700,000 | -8.6% | 250,000 | 0.0% | 0.27% | -4.9% |
| Q1 2021 | $8,423,000 | -6.8% | 250,000 | 0.0% | 0.29% | -1.4% |
| Q4 2020 | $9,033,000 | -68.0% | 250,000 | -67.3% | 0.29% | -70.2% |
| Q3 2020 | $28,190,000 | -18.3% | 765,400 | 0.0% | 0.97% | -35.8% |
| Q2 2020 | $34,489,000 | -5.0% | 765,400 | 0.0% | 1.52% | -38.7% |
| Q1 2020 | $36,318,000 | -33.8% | 765,400 | 0.0% | 2.48% | -20.2% |
| Q4 2019 | $54,849,000 | +61.0% | 765,400 | -11.6% | 3.10% | +25.6% |
| Q3 2019 | $34,062,000 | -29.2% | 865,400 | +40.6% | 2.47% | -40.3% |
| Q2 2019 | $48,094,000 | -15.1% | 615,400 | -35.2% | 4.14% | -36.9% |
| Q1 2019 | $56,668,000 | +63.9% | 950,000 | -20.8% | 6.55% | +53.4% |
| Q4 2018 | $34,584,000 | – | 1,200,000 | – | 4.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |